Status:
UNKNOWN
Toxicity and Efficacy Evaluation of Topical Minoxidil in Acne Vulgaris
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Acne Vulgaris
Eligibility:
All Genders
20-50 years
Phase:
PHASE1
PHASE2
Brief Summary
Patients with acne vulgaris (AV) appeared to be a chronic inflammation with a wide range in teenagers and adult. The protocol design is as follows. The subjects enrolled through inclusion and exclusi...
Detailed Description
1. Background 1.1 Overview of disease pathogenesis, epidemiology and current treatments Patients with acne vulgaris (AV) appeared to be a chronic inflammation with a wide range in teenagers and adult....
Eligibility Criteria
Inclusion
- Gender: both
- Age limit: 20\~50 year/old
- Acne vulgaris: mild to moderate degree (Investigator's Global Assessment Scale:2\~3)
Exclusion
- pregnant or breast feeding woman
- allergic to minoxidil or any ingredient of minoxidil solution including alcohol and propylene glycol
- deny to discontinue topical therapy of acne more than 7 days before starting treatment
- deny to discontinue systemic therapy of acne more than 28 days before starting treatment
- alopecia under or ever using minoxidil, known androgen-AR pathway blocker
- using shampoo containing minoxidil component in 28 days before starting treatment
- irregular menstruation of known case of polycystic ovarian syndrome
- Have had a facial procedure 2 weeks before the study start
- using any oral contraceptives that have a specific anti-androgenic action 12 weeks before the study start
Key Trial Info
Start Date :
July 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06108193
Start Date
July 11 2023
End Date
December 31 2023
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Linkou Chang Gung Memorial Hospital
Taoyuan District, Taiwan, 333